The Journal of Immunology, 2000, 165: 4153-4157.
Copyright © 2000 by The American Association of Immunologists
Cutting Edge: B Cell Linker Protein Is Dispensable for the Allelic Exclusion of Immunoglobulin Heavy Chain Locus But Required for the Persistence of CD5+ B Cells1
Shengli Xu,
Siew-Cheng Wong and
Kong-Peng Lam2
Institute of Molecular and Cell Biology, Singapore, Republic of Singapore
 |
Abstract
|
|---|
The pre-B cell
receptor
(pre-BCR) and the BCR are required for B lymphopoiesis and for the
allelic exclusion of Ig genes. Mice lacking B cell linker (BLNK)
protein that is a component of the BCR signaling pathway have impaired
B cell development. In this report, we show that allelic exclusion is
intact in BLNK-/- mice harboring a VH12
transgene. This differs from mice lacking the tyrosine kinase Syk that
is upstream of BLNK in BCR signaling and contrasts with mice lacking
SLP-76 that is the equivalent adaptor molecule in TCR-signal
transduction. We also show that, whereas most wild-type
VH12-expressing B cells are CD5+, the majority
of the splenic VH12-expressing BLNK-/- B
cells are CD5-. A small population of
VH12-expressing, BLNK-/- CD5+ B
cells is detectable in the peritoneal cavity of younger but not older
mice. This suggests that BLNK deficiency affects not only the
generation but also the persistence of B-1
cells.
 |
Introduction
|
|---|
In developing B lymphocytes, successful gene rearrangements
at the IgH locus permits the formation of a pre-B cell receptor
(pre-BCR)3 complex that
comprises the IgH chain, the surrogate light (L) chains
5 and VpreB
and the signal-transducing subunits Ig
and Igß (1).
The pre-BCR plays a central role in B cell development
(2). It signals the pro-B to pre-B cell transition during
B lymphopoiesis and mediates the allelic exclusion of the IgH locus in
which V(D)J recombination and subsequent heavy (H) chain expression on
the second allele is inhibited. This is evident by the targeted
disruption of Igß (3),
5 (4), or the
transmembrane portion of the µ H chain (5), all of which
compromised the surface expression of the pre-BCR and lead to a block
in B lymphopoiesis and an impairment in IgH allelic exclusion (6, 7).
The BCR replaces the pre-BCR as the central molecule regulating the
fate of mature B lymphocytes. Continuous expression of the BCR is
required for the persistence of peripheral B cells (8).
Engagement of the BCR by self-Ag leads to receptor editing
(9) or clonal deletion (10) of autoreactive B
lymphocytes, whereas triggering of BCR by foreign Ag leads to the
activation, proliferation, and differentiation of Ag-specific B cells
(2). Furthermore, the specificity of the BCR may also
determine the development of B-1 and B-2 cell that are distinguishable
from each other by their cell surface phenotype (11).
Although past studies have indicated the importance of the pre-BCR and
BCR in the differentiation and activation of B cells, the signaling
cascades that mediate the different cellular responses remain partially
elucidated. It is known that cross-linking of the BCR activates
cytoplasmic tyrosine kinases such as Syk, Lyn, Blk, and Brutons
tyrosine kinase (12). Recently, adaptor proteins have
been shown to interface tyrosine kinase activation with selective
downstream molecules (13) and, therefore, could channel
BCR signaling to elicit specific cellular responses. One such adaptors
in B cells is the B cell linker (BLNK) (14), otherwise
known as SLP-65 (15) or BASH (16), which
couples activated Syk to PLC-
, Vav, Grb2, and Nck
(17).
We and others have generated mice lacking BLNK (18, 19, 20, 21).
BLNK-/- B cells do not proliferate upon
anti-IgM stimulation and fail to mount a T cell-independent immune
response. In addition, BLNK-/- mice lack
CD5+ B cells (18, 19, 20, 21). To further
dissect the role of BLNK in B cell development, we now introduced a
transgenic VH12 H chain that is enriched in the
normal B-1 cell population into BLNK-/- mice to
analyze the role of BLNK in IgH allelic exclusion and in the
development of CD5+ B cells.
 |
Materials and Methods
|
|---|
Mice
BLNK-/- (18) and
VH12f (22) mice had been described
previously. BALB/c and C57BL/6 mice were obtained from the Animal
Resource Center in Australia.
Antibodies
The following mAbs were purchased from PharMingen (San Diego,
CA): anti-IgM (R6-60.2), anti-µa
(DS-1), anti-µb (AF6-78.25), anti-B220
(RA3-6B2), anti-CD5 (53.7), and anti-CD43 (S7). The
anti-VH12 (5C5) mAb was obtained from
Dr. G. Haughton (University of North Carolina, Chapel Hill,
NC).
Flow cytometry
Cells were obtained by injecting PBS containing 3% FCS and
0.1% NaN3 into the femurs and tibia or
peritoneal cavity (PerC) of mice. PBL were obtained from mice by tail
bleed and isolated on a density gradient of Lymphoprep (Nycomed,
France). For FACS analyses, cells were stained with FITC-, PE-, and
biotin-conjugated mAbs for 10 min on ice and washed twice with PBS.
Biotin-conjugated mAbs were revealed with streptavidin-Cychrome. FACS
analyses were performed on a FACScan (Becton Dickinson, Mountain View,
CA) and cell sorting was done on a FACSort.
Analyses of IgH gene rearrangements
PCR was performed on genomic DNA obtained from sorted
B220+CD43+ IgM-
bone marrow B cells of wild-type; VH12f/+,
BLNK+/+ and VH12f/+,
BLNK-/- mice for a total of 35 cycles at 94°C
for 1 min, 60°C for 2 min, and 72°C for 10 min using the following
primers (23): DH,
5'-G(A/C)TT TTTGT(G/C)AAGGGATCTACTACTGTG-3';
VHJ558,
5'-TCCA(A/G)CACAGCCT(A/T)CATGCA(A/G)CTCA(A/G)C-3';
VH7183,
5'-AAGAA(C/G)A(A/G)CCTGT(A/T)CCTGCAAATGA(C/G)C-3';
VHQ52,
5'-AGACTGA(A/G)CATCA(C/G)CAAGGACAA(C/T)TCC-3'; and
JH4, 5'-TCCCTCAAATGAGCCTCCAAAGTCC-3'.
The PCR products were subsequently analyzed by Southern blotting using
the 32P-end-labeled JH3
probe, 5'-TTCTCACAAGAGTCCGATAGACCCTGG-3'.
 |
Results and Discussion
|
|---|
Intact allelic exclusion of IgH locus in BLNK-/- B
cells
Each B cell expresses an Ab of a unique specificity comprising of
one H and L chain pair even though it possesses two H and four L chain
(
and
) alleles. Similarly, each T cell expresses a TCR of a
single specificity even though it possesses two alleles each for
and ß as well as
and
genes. This phenomenon is known as
allelic exclusion (2). The exact mechanism regulating the
allelic exclusion of Ag receptor genes is poorly understood although a
signal mediated by the pre-BCR or pre-TCR is necessary for the process
to occur (7, 24). In developing thymocytes, signaling via
the pre-TCR activates the tyrosine kinases Lck, ZAP-70, and Syk, and
adaptor proteins such as SLP-76, Vav, and Cbl further propagate the
signals downstream (13). Studies have indicated that some
of these molecules are involved in signaling allelic exclusion in T
cells, e.g., an activated lck transgene is sufficient to
inhibit TCR ß-chain gene rearrangements in thymocytes
(25). Recently, the adaptor protein SLP-76 that is
involved in TCR signaling is shown to be essential for the allelic
exclusion of TCR ß locus (26). Given the similarities in
BCR and TCR signaling pathways, namely the activation of cytoplasmic
tyrosine kinases and propagation of signals by adaptor proteins, and
that BLNK is the adaptor protein equivalent to SLP-76, we examined IgH
allelic exclusion in BLNK-/- mice.
A VH12 transgene inserted into one of the two IgH
loci by gene-targeting (22) was introduced into
BLNK-/- mice. As shown previously
(18) and in Fig. 1
, BLNK-/- B cells predominantly accumulate at the
B220+CD43+ pro-B to large
pre-B cell stage of differentiation. The introduction of a functional
VH12 transgene did not lead to further
differentiation of BLNK-/- B cells into
B220+CD43- small pre-B
cells. This is not surprising as BLNK-/- B
cells are arrested at a developmental stage whereby surface expression
of the pre-BCR already occurred (21).

View larger version (53K):
[in this window]
[in a new window]
|
FIGURE 1. A VH12 transgene did not rescue the B cell developmental
block in BLNK-/- mice. Bone marrow cells from wild-type;
IgH+/+, BLNK-/-; VH12f/+,
BLNK+/+; and VH12f/+, BLNK-/-
mice were stained with anti-B220, anti-IgM, and anti-CD43
mAbs. The numbers indicate percent of total cells.
|
|
To determine whether BLNK is essential for IgH allelic exclusion, we
performed PCR on genomic DNA isolated from FACS-sorted
B220+CD43+IgM-
bone marrow B cells (Fig. 1
, boxed) of either wild-type;
VH12f/+, BLNK+/+; or
VH12f/+, BLNK-/- mice.
The expression of an IgH transgene in pro-B cells leads to the early
assembly of a pre-BCR that signals allelic exclusion by suppressing
VH to
DHJH rearrangement at the
other endogenous H chain gene locus (23). As expected and
shown in Fig. 2
B (upper
panel), VH12f/+ mice bearing wild-type or
mutant blnk alleles showed some levels of
DH to JH gene
rearrangements at the other IgH locus, similar to normal mice. However,
in contrast to wild-type mice where the rearrangement of
VHJ558, VH7183, and
VHQ52 gene family members to
DH and downstream JH1, 2,
or 3 gene segments can be detected, such gene rearrangement at the
other IgH locus is severely suppressed in VH12f/+
mice bearing either the normal or inactivated alleles of
blnk. The lack of VH to
DHJH gene rearrangements
would suggest that the mechanism maintaining IgH allelic exclusion is
intact in BLNK-/- mice bearing a
VH12 transgene.

View larger version (20K):
[in this window]
[in a new window]
|
FIGURE 2. Intact IgH allelic exclusion in BLNK-/- mice.
A, Schematic representation of the PCR strategy used to
detect DH to JH and VHJ558,
VH7183, or VHQ52 to
DHJH gene rearrangements at the IgH loci.
Arrowheads show the positions of the VH family-,
DH-, and JH4-specific primers used in the PCR.
The JH3-specific probe used in the Southern blot
hybridization is indicated as a black rectangle. The configuration of
the rearranged VH12 insertion allele is also shown.
B, Southern blot analyses of PCR products derived from
the amplification of genomic DNA obtained from sorted
B220+CD43+IgM- B cells (Fig. 1 , boxed) of IgH+/+, BLNK+/+
(lane 1); VH12f/+, BLNK+/+
(lane 2); and VH12f/+, BLNK-/-
(lane 3) mice using JH4 and DH
(top panel); JH4 and VHJ558,
VH7183, or VHQ52 (middle 3
panels) primers. The positions corresponding to the
rearrangements of DH or VH to either the
JH1, 2, or 3 gene segments are shown. The housekeeping gene
GADPH was amplified as a control for the amount of genomic DNA used in
the PCR (bottom panel).
|
|
To confirm that BLNK-/- B cells indeed maintain
allelic exclusion at the IgH loci, we generated wild-type and
BLNK-/- mice that possess both the
IgMa and IgMb alleles. As
shown in Fig. 3
, FACS analysis of PBL in
BLNK-/- mice indicates that the B cells present
express either IgMa or IgMb
but not both molecules on their cell surfaces. This is similar to the B
cells found in wild-type mice bearing the two different IgM alleles.
The lack of a sizeable population of B cells that coexpress
IgMa and IgMb in
BLNK-/- mice would again suggest that signal(s)
transduced by BLNK is not required for the allelic exclusion of the
IgH loci.

View larger version (44K):
[in this window]
[in a new window]
|
FIGURE 3. FACS analyses of PBL of wild-type and BLNK-/- mice
bearing IgMa,b alleles. Cells are stained with
anti-µa and anti-µb mAbs. BALB/c
(IgMa,a) and C57BL/6 (IgMb,b) mice are included
as controls for the specificity of the reagents. The numbers indicate
percent of total lymphocytes.
|
|
Thus, our data presented in this report indicate that BLNK is not
essential for the allelic exclusion of Ig genes. This contrasts
significantly with the impairment of TCR ß-chain allelic exclusion in
SLP-76-/- mice (26) and suggests
that the intracellular signaling pathway controlling allelic exclusion
in B and T cells may differ in some aspects. The current finding is
also interesting as BLNK is a direct downstream substrate of Syk in BCR
signaling (14, 17). Previous analysis of
Syk-/- mice had indicated that this tyrosine
kinase is involved in mediating allelic exclusion of Ig genes in B
cells (27). Our data would suggest that bifurcation of
signal transduction occurs downstream of Syk such that perhaps another
signaling molecule but not BLNK is responsible for transducing the
signal for IgH allelic exclusion in B cells.
Role of BLNK in the generation and persistence of
CD5+ B cells
CD5+ B cells are distinguishable from the
majority of the conventional B cells by their unique cell surface
phenotype and anatomical localization (11). The origins of
these cells remain controversial (11) although certain BCR
specificities seem to bias their generation in the mouse
(29). We and others previously showed that
BLNK-/- mice lack CD5+ B
cells (18, 19, 20, 21). The absence of CD5+
B cells in BLNK-/- mice could be due to
impairment in the generation and/or persistence of this B cell subset.
To explore these possibilities, we examined the B cell populations in
BLNK-/- mice bearing a
VH12 transgene. The VH12 H
chain is used preferentially in the recognition of phosphatidylcholine
and B cells expressing this specificity predominantly differentiate
into CD5+ B cells and are heavily selected in
vivo (28).
Splenic B cells obtained from wild-type or
BLNK-/- mice carrying the
VH12 transgene stably expressed the H chain as
shown by the anti-VH12 specific mAb staining
in FACS analysis (Fig. 4
, upper
panel). However, the introduction of the
VH12 transgene into
BLNK-/- mice did not lead to a significant
increase in the number of peripheral B cells in these mice (Table I
). At 12 wk of age, there is respectively, a
4- and 25- to 100-fold reduction in the number of B cells in the spleen
and PerC of VH12f/+,
BLNK-/- mice compared with wild-type or
VH12f/+, BLNK+/+ mice of
similar age.

View larger version (60K):
[in this window]
[in a new window]
|
FIGURE 4. The majority of the VH12-expressing BLNK-/- B
cells are CD5-. FACS analyses of splenic (top two
panels) and PerC (bottom panel) cells obtained
from 4-wk-old mice of various genotypes. Cells were stained with
anti-IgM and anti-VH12 (top panel)
or anti-CD5 and anti-IgM (middle and bottom
panels) mAbs. The numbers indicate percent of total
lymphocytes.
|
|
CD5+ B cells constitute a small subset of B cells
in the spleen of normal mice. In VH12f/+,
BLNK+/+ mice, a large fraction (>75%) of the
splenic B cells are CD5+, indicating that the
enforced expression of VH12 leads to the
preferential development of B-1 cells. These cells express low levels
of B220 and the majority of them are also CD43+
and CD23- (data not shown), in agreement with
previous reports (22, 28). However, in
VH12f/+ mice lacking BLNK, most of the splenic
VH12-expressing B cells are now
CD5- (Fig. 3
, middle panel) and they
express high levels of B220 and do not express CD23 (data not
shown).
Examination of the PerC of VH12f/+,
BLNK-/- mice also indicates that a proportion
(30% to 50%) of the VH12-expressing B cells are
CD5- (Fig. 4
, bottom panel and Fig. 5
, top panel), in contrast to the
VH12-expressing cells in the PerC of
VH12f/+, BLNK+/+ mice in
which >90% of the B cells present express the CD5 Ag. However,
CD5-expressing VH12-B cells can develop in the
PerC of young 4-wk-old VH12f/+,
BLNK-/- mice although they are fewer in numbers
compared with the cells in VH12f/+,
BLNK+/+ mice (Fig. 4
, bottom panel and
Table I
).

View larger version (40K):
[in this window]
[in a new window]
|
FIGURE 5. BLNK is required for the persistence of CD5+ B cells. FACS
analysis of PerC cells obtained from 4- and 12-wk-old mice of various
genotypes. Cells were stained with FITC-anti-IgM and
PE-anti-CD5 mAbs. The CD5+IgM+ B cells are
boxed and expressed as a percentage of total IgM+ B cells
present. Figure shown is representative of >5 analyses.
|
|
CD5+ B cells are thought to be long-lived and to
undergo a self-renewal process (11). To determine whether
the small population of CD5+
VH12-expressing B cells persist and clonally
expand in the absence of BLNK, we examined the PerC cells of older
VH12f/+, BLNK-/- mice. In
normal mice, the population of CD5+ B cells
expanded as the mice aged (Fig. 5
). In BLNK-/-
mice, CD5+ B cells were largely absent in both
the younger and older animals. Interestingly, whereas
CD5+ B cells can be found in younger
VH12f/+, BLNK-/- mice and
comprise up to
50% of the B cells present, these cells are absent
in the PerC of older VH12f/+,
BLNK-/- mice.
Our data show that most splenic VH12-expressing
BLNK-/- B cells assume a B-2 cell phenotype
even though they are constrained by transgenesis to express a BCR that
is preferentially enriched in the normal B-1 cell population.
Therefore, BLNK deficiency affects the generation of B-1 cells.
This observation is similar to that of
VH12-expressing B cells lacking the tyrosine
kinase Brutons tyrosine kinase (29) and is consistent
with the idea that BCR-signaling may be required for the
generation of B-1 cells (30).
Because our mice are polyclonal with respect to Ig L chain usage, it is
likely that VH12 in combination with certain L
chains generate some BCR whose signaling are strong enough to
compensate for BLNK deficiency and, therefore, drive the
differentiation of B cells expressing these BCRs into the B-1 cell
compartment. This could explain the presence of a small population of
B-1 cells in the PerC of VH12f/+,
BLNK-/- mice. What is surprising is that these
CD5+ B cells are not found in the older mutant
animals. B-1 cells are thought to be long-lived, undergo self-renewal,
and clonally expand in older mice (11). Our data suggest
that the persistence and/or self-renewal of B-1 cells would also
require signaling from the BCR, and this is affected by the
inactivation of BLNK. Future experiments involving the enforced
expression of cell survival genes such as Bcl-2 and/or Bcl-xL in
VH12f/+, BLNK-/- mice may
determine whether CD5+ B cells indeed fail to
survive in the absence of BLNK.
 |
Footnotes
|
|---|
1 Supported by grants from the National Science and Technology Board of Singapore. 
2 Address correspondence and reprint requests to Dr. Kong-Peng Lam, Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609, Republic of Singapore. 
3 Abbreviations used in this paper: pre-BCR, pre-B cell receptor; BLNK, B cell linker; H, heavy; L, light; PerC, peritoneal cavity. 
Received for publication June 16, 2000.
Accepted for publication August 14, 2000.
 |
References
|
|---|
-
Reth, M., J. Wienands. 1997. Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15:453.[Medline]
-
Rajewsky, K.. 1996. Clonal selection and learning in the antibody system. Nature 381:751.[Medline]
-
Gong, S., M. C. Nussenzweig. 1996. Regulation of an early developmental checkpoint in the B cell pathway by Igß. Science 272:411.[Abstract]
-
Kitamura, D., A. Kudo, S. Schaal, W. Muller, F. Melchers, K. Rajewsky. 1992. A critical role of
5 protein in B cell development. Cell 69:823.[Medline]
-
Kitamura, D., J. Roes, R. Kuhn, K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin µ-chain gene. Nature 350:423.[Medline]
-
Kitamura, D., K. Rajewsky. 1992. Targeted disruption of the µ-chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154.[Medline]
-
Loffert, D., A. Ehlich, W. Muller, K. Rajewsky. 1996. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity 4:133.[Medline]
-
Lam, K.-P., R. Kuhn, K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073.[Medline]
-
Nemazee, D.. 2000. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18:19.[Medline]
-
Goodnow, C. C.. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93:2264.[Abstract/Free Full Text]
-
Kantor, A. B., L. A. Herzenberg. 1990. Origin of murine B cell lineages. Annu. Rev. Immunol. 11:501.[Medline]
-
Satterthwaite, A., O. Witte. 1996. Genetic analysis of tyrosine kinase function in B cell development. Annu. Rev. Immunol. 14:131.[Medline]
-
Peterson, E. J., J. L. Clements, N. Fang, G. A. Koretzky. 1998. Adaptor proteins in lymphocyte antigen-receptor signaling. Curr. Opin. Immunol. 10:337.[Medline]
-
Fu, C., C. W. Turck, T. Kurosaki, A. C. Chan. 1998. BLNK: a central linker protein in B cell activation. Immunity 9:93.[Medline]
-
Wienands, J., J. Schweikert, B. Wollscheid, H. Jumma, P. J. Nielsen, M. Reth. 1998. SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J. Exp. Med. 18:791.
-
Goitsuka, R., Y. Fujimura, H. Mamada, A. Umeda, T. Morimura, K. Uetsuka, K. Doi, S. Tsuji, D. Kitamura. 1998. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius. J. Immunol. 161:5804.[Abstract/Free Full Text]
-
Ishiai, M., M. Kurosaki, R. Pappu, K. Okawa, I. Ronko, C. Fu, M. Shibata, A. Iwamatsu, A. C. Chan, T. Kurosaki. 1999. BLNK required for coupling Syk to PLC
2 and Rac1-JNK in B cells. Immunity 10:117.[Medline]
-
Xu, S., J. E.-L. Tan, E. P.-Y. Wong, A. Manickam, S. Ponniah, K.-P. Lam. 2000. B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int. Immunol. 12:397.[Abstract/Free Full Text]
-
Jumma, H., R. Wollscheid, M. Mitterer, J. Wienands, M. Reth, P. J. Nielsen. 1999. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11:547.[Medline]
-
Pappu, R., A. M. Cheng, B. Li, Q. Gong, C. Chiu, N. Griffin, M. White, B. P. Sleckman, A. C. Chan. 1999. Requirement for B cell linker protein (BLNK) in B cell development. Science 286:1949.[Abstract/Free Full Text]
-
Hayashi, K., R. Nittono, N. Okamoto, S. Tsuji, Y. Hara, R. Goitsuka, D. Kitamura. 2000. The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells. Proc. Natl. Acad. Sci. USA 97:2755.[Abstract/Free Full Text]
-
Lam, K.-P., K. Rajewsky. 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190:471.[Abstract/Free Full Text]
-
Iritani, B. M., J. Alberola-Ila, K. A. Forbush, R. M. Perlmutter. 1999. Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. Immunity 10:713.[Medline]
-
Aifantis, I., J. Buer, H. von Boehmer, O. Azogui. 1997. Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor ß locus. Immunity 7:601.[Medline]
-
Anderson, S. J., K. M. Abraham, T. Nakayama, A. Singer, R. M. Perlmutter. 1992. Inhibition of T-cell receptor ß-chain gene rearrangement by over-expression of the non-receptor tyrosine kinase p56lck. EMBO J. 11:4877.[Medline]
-
Aifantis, I., V. I. Pivniouk, F. Gartner, J. Feinberg, W. Swat, F. W. Alt, H. V. Boehmer, R. S. Geha. 1999. Allelic exclusion of the T cell receptor ß locus requires the SH2 domain-containing leukocyte protein (SLP)-76 adaptor protein. J. Exp. Med. 190:1093.[Abstract/Free Full Text]
-
Cheng, A. M., B. Rowley, W. Pao, A. Hayday, J. B. Bolen, T. Pawson. 1995. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378:303.[Medline]
-
Arnold, L. W., C. A. Pennell, S. K. McCray, S. H. Clarke. 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179:1585.[Abstract/Free Full Text]
-
Clarke, S. H., L. W. Arnold. 1998. B-1 cell development: evidence for an uncommitted immunoglobulin IgM+ B cell precursor in B-1 cell differentiation. J. Exp. Med. 187:1325.[Abstract/Free Full Text]
-
Haughton, G., L. W. Arnold, A. C. Whitmore, S. H. Clarke. 1993. B-1 cells are made, not born. Immunol. Today. 14:84.[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
S. Xu, K.-G. Lee, J. Huo, T. Kurosaki, and K.-P. Lam
Combined deficiencies in Bruton tyrosine kinase and phospholipase C{gamma}2 arrest B-cell development at a pre-BCR+ stage
Blood,
April 15, 2007;
109(8):
3377 - 3384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xu, J. Huo, W.-K. Chew, M. Hikida, T. Kurosaki, and K.-P. Lam
Phospholipase C{gamma}2 Dosage Is Critical for B Cell Development in the Absence of Adaptor Protein BLNK.
J. Immunol.,
April 15, 2006;
176(8):
4690 - 4698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Pike and M. J. H. Ratcliffe
Dual Requirement for the Ig{alpha} Immunoreceptor Tyrosine-Based Activation Motif (ITAM) and a Conserved Non-Ig{alpha} ITAM Tyrosine in Supporting Ig{alpha}{beta}-Mediated B Cell Development
J. Immunol.,
February 15, 2005;
174(4):
2012 - 2020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hayashi, T. Nojima, R. Goitsuka, and D. Kitamura
Impaired Receptor Editing in the Primary B Cell Repertoire of BASH-Deficient Mice
J. Immunol.,
November 15, 2004;
173(10):
5980 - 5988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xu and K.-P. Lam
Delayed Cellular Maturation and Decreased Immunoglobulin {kappa} Light Chain Production In Immature B Lymphocytes Lacking B Cell Linker Protein
J. Exp. Med.,
July 15, 2002;
196(2):
197 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E.-L. Tan, S.-C. Wong, S. K.-E. Gan, S. Xu, and K.-P. Lam
The Adaptor Protein BLNK Is Required for B Cell Antigen Receptor-induced Activation of Nuclear Factor-kappa B and Cell Cycle Entry and Survival of B Lymphocytes
J. Biol. Chem.,
June 1, 2001;
276(23):
20055 - 20063.
[Abstract]
[Full Text]
[PDF]
|
 |
|